| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/2014 | US8759290 Oral glucagon-like peptide conjugates for metabolic diseases |
| 06/24/2014 | US8759289 Method for sensitizing cancer stem cells to cancer therapy |
| 06/24/2014 | US8759287 Methods of decreasing incisional hernia formation and acute wound failure in obese patients by administering basic fibroblast growth factor |
| 06/24/2014 | US8759286 Pharmaceutical compositions comprising a VEGF-D polypeptide |
| 06/24/2014 | US8759285 VEGF superagonists and methods of use |
| 06/24/2014 | US8759283 Methods for detecting mRNA and/or protein levels of gene in a biological sample |
| 06/24/2014 | US8759281 Antigen delivery vectors and constructs |
| 06/24/2014 | US8759097 Inhibition of dynamin related protein 1 to promote cell death |
| 06/24/2014 | US8759063 DNA polymerases with improved activity |
| 06/24/2014 | US8759060 PEG-modified arginine/lysine oxidoreductase |
| 06/24/2014 | US8759006 PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia |
| 06/24/2014 | US8759004 Compounds and methods for detection of carcinomas and their precursor lesions |
| 06/24/2014 | US8758841 Cheese capable of disinfecting Helicobacter pylori |
| 06/24/2014 | US8758833 Cosmetic composition for the treatment of acne comprising a peptide extract of Schisandra |
| 06/24/2014 | US8758822 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs |
| 06/24/2014 | US8758811 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 06/24/2014 | US8758806 Human lubrication gel |
| 06/24/2014 | US8758791 Highly compression resistant matrix with porous skeleton |
| 06/24/2014 | US8758778 Polymeric nano-carriers with a linear dual response mechanism and uses thereof |
| 06/24/2014 | US8758771 Bacterial virulence factors and uses thereof |
| 06/24/2014 | US8758770 Alpha-MSH therapies for treatment of autoimmune disease |
| 06/24/2014 | US8758767 Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof |
| 06/24/2014 | US8758759 Transmucosal administration of aggregated antigens |
| 06/24/2014 | US8758747 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 06/24/2014 | US8758746 Fertilization modulation compounds and process for implementing them |
| 06/24/2014 | US8758745 Use of GSTP1 |
| 06/24/2014 | US8758744 Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly α-1,2 branched dextran |
| 06/24/2014 | US8758743 Compositions containing coenzyme Q10 |
| 06/24/2014 | US8758517 Process for the hydrolysis of cellulose |
| 06/19/2014 | WO2014093773A1 Methods and assays relating to macrophage differentiation |
| 06/19/2014 | WO2014093387A1 Vegf receptor fusion proteins for veterinary use |
| 06/19/2014 | WO2014093354A1 Fusion of human growth hormone and albumin, formulation and uses thereof |
| 06/19/2014 | WO2014093251A1 Engineered receptors and their use |
| 06/19/2014 | WO2014093240A1 Bivalent il-2 fusion toxins |
| 06/19/2014 | WO2014092596A1 Substances and pharmaceutical compositions based thereon for treating human diseases, including chronic hepatitis b and c |
| 06/19/2014 | WO2014092239A1 Tissue sealant in which collagen and fibrin are mixed, and method for preparing same |
| 06/19/2014 | WO2014092150A1 Myoblast differentiation accelerator |
| 06/19/2014 | WO2014091980A1 Hyaluronic acid composition |
| 06/19/2014 | WO2014091239A1 Novel pharmaceutical formulations and their use in the treatment of periodontal disease |
| 06/19/2014 | WO2014091034A1 Novel mhc-independent tumor-associated antigens |
| 06/19/2014 | WO2014090948A1 Serpin spn4a and biologically active derivatives thereof for use in the treatment of cancer |
| 06/19/2014 | WO2014090800A1 Novel interleukin-33 inhibitors |
| 06/19/2014 | WO2014090546A1 Compositions for oral use containing collagen and elastin hydrolysates and vitamin c, which promote the deposit of extracellular matrix |
| 06/19/2014 | WO2014090266A1 P16ink4a derived peptides for prophylaxis and therapy of hpv-associated tumors and other p16 expressing tumors |
| 06/19/2014 | WO2014090224A1 Use of active substance combinations for inducing tumour senescence |
| 06/19/2014 | WO2014090184A1 Biologically active polypeptide qepvl and preparation and use thereof |
| 06/19/2014 | WO2014090183A1 Biologically active polypeptide lplp and preparation and use thereof |
| 06/19/2014 | WO2014090180A1 Biologically active polypeptide qepv and preparation and use thereof |
| 06/19/2014 | WO2014090172A1 Biologically active polypeptide delq and preparation and use thereof |
| 06/19/2014 | WO2014090167A1 Nanoscale insulin and preparation method thereof |
| 06/19/2014 | WO2014090152A1 Use of nerve growth factor in preparing drug for treating hypogonadism syndrome in middle-aged and elderly males |
| 06/19/2014 | WO2014089610A1 Scalable three-dimensional elastic construct manufacturing |
| 06/19/2014 | WO2014074186A3 Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities |
| 06/19/2014 | WO2014066487A3 Methods for treating anemia |
| 06/19/2014 | WO2014063704A3 M. tuberculosis vaccines |
| 06/19/2014 | WO2014052451A3 Insulin analog dimers |
| 06/19/2014 | WO2014049556A3 Neurotrophin-tyrosine kinase receptor signaling |
| 06/19/2014 | WO2013176667A3 Maspin-based treatment and prevention of cancer |
| 06/19/2014 | WO2013166448A8 Stable formulations containing anti-pcsk9 antibodies |
| 06/19/2014 | US20140171378 Leucine-Rich Peptide Compositions and Methods for Isolation |
| 06/19/2014 | US20140171374 Use of a truncated eif-5a1 polynucleotide to induce apoptosis in cancer cells |
| 06/19/2014 | US20140171372 Treatments for Alzheimer's disease |
| 06/19/2014 | US20140171370 Formulations of active agents for sustained release |
| 06/19/2014 | US20140171369 Pharmaceutical Composition |
| 06/19/2014 | US20140171367 Polymer Hydrogels For In Vivo Applications And Methods For Using And Preparing Same |
| 06/19/2014 | US20140171366 Compounds and methods for treating cancer |
| 06/19/2014 | US20140171364 Stable glucagon formulations for the treatment of hypoglycemia |
| 06/19/2014 | US20140171362 Stable formulations for parenteral injection of peptide drugs |
| 06/19/2014 | US20140171361 Methods for treating metabolic disorders using fgf |
| 06/19/2014 | US20140171359 Diagnosis of respiratory tract infectious diseases using urine specimens |
| 06/19/2014 | US20140171356 Chemically immobilized wnt protein and methods of use |
| 06/19/2014 | US20140170728 Factor IX: Remodeling and Glycoconjugation of Factor IX |
| 06/19/2014 | US20140170221 Methods and compositions for localized delivery of agents to virally infected cells and tissues |
| 06/19/2014 | US20140170212 Stable digestive enzyme compositions |
| 06/19/2014 | US20140170197 Polymeric delivery systems for active agents |
| 06/19/2014 | US20140170185 Emulsion containing a non-live medicinal substance |
| 06/19/2014 | US20140170177 Food Supplement Having High Immunological Value, Based On A Protein Matrix |
| 06/19/2014 | US20140170173 Method of inducing immune tolerance comprising administering carbonic anhydrase i |
| 06/19/2014 | US20140170172 Tat-Based Tolerogen Compositions and Methods for Making and Using Same |
| 06/19/2014 | US20140170165 Methods of generating hyper inos expressing cells and uses thereof |
| 06/19/2014 | US20140170162 Preservation of the neuromuscular junction (nmj) after traumatic nerve injury |
| 06/19/2014 | US20140170143 Use of an anti-cd200 antibody for prolonging the survival of allografts |
| 06/19/2014 | US20140170133 Alteration of proteolytic cleavage of botulinum neurotoxins |
| 06/19/2014 | US20140170132 Prophylatic treatment of herpes recurrence |
| 06/19/2014 | US20140170128 Compositions for the management of glycated hemoglobin and blood glucose |
| 06/19/2014 | US20140170125 Use of cardiotrophin-1 for the treatment of kidney diseases |
| 06/19/2014 | US20140170119 Multi-chamber applicator for gelatin solution |
| 06/19/2014 | US20140170116 Method of treating ischemic disorders |
| 06/19/2014 | US20140170115 Enzyme and Prebiotic Combinations for Enhancing Probiotic Growth and Efficacy |
| 06/19/2014 | US20140170112 Compositions for ameliorating systemic inflammation and methods for making and using them |
| 06/19/2014 | US20140170108 Compositions useful for the treatment of inflammatory disease or disorders |
| 06/19/2014 | US20140170107 Regulation of energy metabolism and obesity by modulating b cell activating factor (baff, blys) or baff signaling |
| 06/19/2014 | US20140170063 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity |
| 06/18/2014 | EP2742953A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 06/18/2014 | EP2742950A1 Pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells |
| 06/18/2014 | EP2742949A1 Factor VIII B cell epitope variants having reduced immunogenicity |
| 06/18/2014 | EP2742948A1 Use of cardiotrophin-1 for the treatment of kidney diseases |
| 06/18/2014 | EP2742947A1 Bilirubin excretion enhancer |
| 06/18/2014 | EP2742133A1 Mphosph1 peptides and vaccines including the same |
| 06/18/2014 | EP2742061A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |